Global Cold Chain Pharmaceutical Logistics Service Market Strategic Research Report

Scope of the Report

The global Cold Chain Pharmaceutical Logistics Service market size is predicted to grow from US$ 27,450 million in 2025 to US$ 47,820 million in 2032; it is expected to grow at a CAGR of 8.4% from 2026 to 2032.

Cold Chain Pharmaceutical Logistics Service refers to an integrated logistics service system that continuously maintains specific temperature ranges that meet national and international standards throughout the entire supply chain (from manufacturing enterprises, warehousing centers, transportation nodes to hospitals, pharmacies, and other terminals) for temperature-sensitive pharmaceutical products such as drugs, vaccines, biological products, and special medical devices. This system relies on professional temperature control technology, a compliant logistics network, and an information management system. Its core function is to mitigate the risks of reduced potency and deterioration of pharmaceutical products due to temperature fluctuations through end-to-end temperature control and process compliance management, ensuring drug quality and safety for clinical use. It is a crucial supporting link in the pharmaceutical and healthcare industry chain.

The application of technologies such as the Internet of Things (IoT) and blockchain continues to deepen. By 2025, the penetration rate of IoT monitoring devices had increased to 82%, and the coverage rate of blockchain traceability systems reached 65%. By combining these technologies with temperature sensors and GPS, real-time temperature monitoring, anomaly alarms, and tamper-proof data are achieved throughout the entire pharmaceutical transportation process. Logistics companies are also using these technologies to control the damage rate of pharmaceutical transportation to below 0.01%.

Driven by ESG standards, the promotion of electric refrigerated trucks is accelerating, with their share expected to increase from 35% in 2025 to 70% in 2030. The application of new phase change cold storage materials and nano-insulation materials is increasing, not only reducing carbon emissions but also extending the insulation time of refrigerated boxes to 120 hours and expanding the delivery radius in remote areas.

In addition to basic warehousing and transportation, value-added services such as compliance consulting, customized supply chain solutions, and emergency response are emerging. Meanwhile, the integration of medical big data and cold chain systems has spawned a multi-billion dollar value-added service market, such as providing pharmaceutical companies with data services like inventory warnings and demand forecasts, and providing medical institutions with customized services like expedited specimen delivery, becoming a new profit growth point for the industry.

This report presents a comprehensive overview of the global Cold Chain Pharmaceutical Logistics Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Transportation Service of Vaccine Products
• Transport Service of IVD Reagents
• Transport Service of Blood Products
• Other

Segment by Process

• Transportation
• Warehousing
• Packaging
• Others

Segment by Temperature

• Cold Chain Services
• Frozen Chain Services
• Ultra-low Temperature Chain Services

Segment by Application

• Hospitals and Medical Institutions
• Pharmaceutical Enterprise
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Cold Chain Pharmaceutical Logistics Service market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospitals and Medical Institutions, Pharmaceutical Enterprise, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact